Home
Drugs
Carboplatin
Clinical Trials

Clinical Trials Related to Carboplatin

Related studies linked through entity extraction aliases.

Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Status: ACTIVE_NOT_RECRUITING
Phase: NA

Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never Smokers

Status: COMPLETED
Phase: PHASE2

Everolimus, Carboplatin, and Paclitaxel in Locally Advanced Head and Neck Cancer That Cannot Be Removed by Surgery

Status: COMPLETED
Phase: PHASE1/PHASE2

PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy

Status: COMPLETED
Phase: PHASE2

Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel

Status: COMPLETED
Phase: PHASE2

RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation

Status: COMPLETED
Phase: PHASE4

Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer

Status: COMPLETED
Phase: PHASE2

A Study of the Safety and Pharmacology of GDC-0980 in Combination With Either Paclitaxel and Carboplatin (With or Without Bevacizumab) or Pemetrexed and Cisplatin in Patients With Solid Tumors

Status: COMPLETED
Phase: PHASE1

Carboplatin and Bevacizumab for Recurrent Ependymoma

Status: COMPLETED
Phase: PHASE2

Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical Cancer

Status: UNKNOWN
Phase: PHASE1

A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors

Status: COMPLETED
Phase: PHASE1

Concurrent Adjuvant Carboplatin and Accelerated Radiotherapy for Triple Negative Breast Cancer

Status: COMPLETED
Phase: PHASE1/PHASE2

A Study of LY2090314 in Patients With Advanced or Metastatic Cancer

Status: COMPLETED
Phase: PHASE1

Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin

Status: COMPLETED
Phase: PHASE3

A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer

Status: COMPLETED
Phase: PHASE1/PHASE2

A Study of Carboplatin, PLD and Everolimus in Certain Gynecologic Cancer

Status: COMPLETED
Phase: PHASE1

High-Dose or Low-Dose Vorinostat in Combination With Carboplatin or Paclitaxel in Treating Patients With Advanced Solid Tumors

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Status: COMPLETED
Phase: PHASE1

Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer

Status: COMPLETED
Phase: PHASE2

Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer

Status: TERMINATED
Phase: NA